 | Up a level |
Anderegg, Manuel A; Olinger, Eric G; Bargagli, Matteo; Geraghty, Rob; Taylor, Lea; Nater, Alexander; Bruggmann, Rémy; Sayer, John A; Vogt, Bruno; Schaller, André; Fuster, Daniel G (2024). Prevalence and characteristics of genetic disease in adult kidney stone formers. Nephrology, dialysis, transplantation, 39(9), pp. 1426-1441. Oxford University Press 10.1093/ndt/gfae074
Bargagli, Matteo; Trelle, Sven; Bonny, Olivier; Fuster, Daniel G. (2024). Thiazides for kidney stone recurrence prevention. Current Opinion in Nephrology & Hypertension, 33(4), pp. 427-432. Wolters Kluwer Health 10.1097/MNH.0000000000000990
Bargagli, Matteo; Anderegg, Manuel A.; Fuster, Daniel G. (2024). Effects of thiazides and new findings on kidney stones and dysglycemic side effects. Acta physiologica Wiley 10.1111/apha.14155
Lombardi, Gianmarco; Ferraro, Pietro Manuel; De Tomi, Elisa; Bargagli, Matteo; Spasiano, Andrea; Gambaro, Giovanni (2024). Sex differences in chronic kidney disease-related complications and mortality across levels of glomerular filtration rate. (In Press). Nephrology, dialysis, transplantation Oxford University Press 10.1093/ndt/gfae087
Dhayat, Nasser A.; Mattmann, Cédric; Seeger, Harald; Ritter, Alexander; Ernandez, Thomas; Stoermann-Chopard, Catherine; Buchkremer, Florian; Segerer, Stephan; Roth, Beat; Wuerzner, Gregoire; Wagner, Carsten A.; Bonny, Olivier; Popp, Albrecht W.; Vogt, Bruno; Bargagli, Matteo; Fuster, Daniel G. (2024). The Vitamin D metabolite diagnostic ratio associates with phenotypic traits of idiopathic hypercalciuria. Kidney international reports, 9(4), pp. 1072-1082. Elsevier 10.1016/j.ekir.2024.01.004
Bargagli, Matteo; Liguori, Antonio; Napodano, Cecilia; Baroni, Silvia; Tomasello, Lidia; Pizzolante, Fabrizio; De Matthaeis, Nicoletta; De Ninno, Grazia; Grieco, Antonio; Gasbarrini, Antonio; Gambaro, Giovanni; Ferraro, Pietro Manuel; Miele, Luca (2023). Urinary lithogenic profile of patients with non-alcoholic fatty liver disease. Nephrology, dialysis, transplantation, 38(11), pp. 2652-2654. Oxford University Press 10.1093/ndt/gfad106
Kucharczyk, Patrycja; Albano, Giuseppe; Deisl, Christine; Ho, Manh Tin; Bargagli, Matteo; Anderegg, Manuel; Wueest, Stephan; Konrad, Daniel; Fuster, Daniel G. (2023). Thiazides Attenuate Insulin Secretion Through Inhibition of Mitochondrial Carbonic Anhydrase 5b in β-islet Cells in Mice. Journal of the American Society of Nephrology JASN, 34(7), pp. 1179-1190. American Society of Nephrology 10.1681/ASN.0000000000000122
Bargagli, Matteo; Vetsch, Andri; Anderegg, Manuel A; Dhayat, Nasser A; Huynh-Do, Uyen; Faller, Nicolas; Vogt, Bruno; Ferraro, Pietro Manuel; Fuster, Daniel G (2023). Tolvaptan treatment is associated with altered mineral metabolism parameters and increased bone mineral density in ADPKD patients. Nephrology, dialysis, transplantation, 38(7), pp. 1645-1654. Oxford University Press 10.1093/ndt/gfac298
Ferraro, Pietro Manuel; Bargagli, Matteo; Faller, Nicolas; Anderegg, Manuel A; Huynh-Do, Uyen; Vogt, Bruno; Gambaro, Giovanni; Fuster, Daniel G (2023). The role of urinary supersaturations for lithogenic salts in the progression of autosomal dominant polycystic kidney disease. Journal of nephrology JN, 36(4), pp. 1011-1018. Wichtig Editore 10.1007/s40620-022-01540-5
Bargagli, Matteo; Ferraro, Pietro Manuel; Dhayat, Nasser; Anderegg, Manuel; Fuster, Daniel (2021). Effect of Tolvaptan treatment on acid-base homeostasis in ADPKD patients. Kidney international reports, 6(6), p. 1749. Elsevier 10.1016/j.ekir.2021.04.012
Bargagli, Matteo; Dhayat, Nasser A.; Anderegg, Manuel; Semmo, Mariam; Huynh-Do, Uyen; Vogt, Bruno; Ferraro, Pietro Manuel; Fuster, Daniel G. (2020). Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan. Clinical Journal of the American Society of Nephrology, 15(7), pp. 1007-1014. American Society of Nephrology 10.2215/CJN.13861119
Anderegg, Manuel A.; Olinger, Eric G.; Bargagli, Matteo; Geraghty, Rob; Pohlmeier, Lea; Nater, Alexander; Bruggmann, Rémy; Sayer, John A.; Vogt, Bruno; Schaller, André; Fuster, Daniel G. (27 July 2023). Prevalence and characteristics of monogenic disease in adult kidney stone formers (medRxiv). Cold Spring Harbor Laboratory 10.1101/2023.07.23.23292924
